Canadian Manufacturing

Federal government invests $4M in ANVO Laboratories to improve biomanufacturing

by CM Staff   

Exporting & Importing Financing Manufacturing Operations Supply Chain Infrastructure advanced manufacturing biomanufacturing financing Government In Focus Manufacturing pharmaceuticals Research


This investment will support ANVO Labs as it equips and staffs its new 62,000-sq.ft. research, development, and production facility in the Advanced Manufacturing Park in London to manufacture tablets and capsules.

LONDON — On Jul. 12, Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), joined by Peter Fragiskatos, MP for London North Centre, announced an investment of $4 million for ANVO Laboratories (ANVO Labs) to accelerate production to provide domestic medications for gastrointestinal, diabetes, cardiovascular, and neurological diseases to Canadians and more globally.

This investment will support ANVO Labs as it equips and staffs its new 62,000-sq.ft. research, development, and production facility in the Advanced Manufacturing Park in London to manufacture tablets and capsules. The new global headquarters will continue to foster connections with the local health sciences ecosystem, colleges, and universities. It will also assist in attracting and developing a highly-skilled health sciences workforce to strengthen Canada’s healthcare system.

The project will reportedly accelerate production of its specialized packaging for Canadian drug manufacturers, support made-in-Canada pharmaceutical production and strengthen our biomanufacturing supply chain. This investment is making it possible to produce this type of packaging right here in Canada. In turn, this will position Canada as a leader in drug development and production, while creating 45 skilled jobs in London.

“ANVO Laboratories is making incredible strides in the health sciences, and the Government of Canada is supporting them so they can continue to grow. Making smart investments in critical biomanufacturing will strengthen our healthcare system and ensure everyone receives the care they deserve. Our government is helping people reach their potential and turn possibilities into realities,” said Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario.

Advertisement

“This investment is another step that our Government is taking to build the future of Canada—one that is good for workers, good for business, good for everyone,” said Peter Fragiskatos, Member of Parliament for London North Centre.

Advertisement

Stories continue below